{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:49:56Z","timestamp":1791596996283,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260462"],"award-info":[{"award-number":["82260462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350117"],"award-info":[{"award-number":["82350117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32360046"],"award-info":[{"award-number":["32360046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160476"],"award-info":[{"award-number":["82160476"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2024XKTDYS07"],"award-info":[{"award-number":["2024XKTDYS07"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202302AA310043"],"award-info":[{"award-number":["202302AA310043"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010982","name":"Philippine Council for Industry Energy and Emerging Technology Research and Development","doi-asserted-by":"publisher","award":["202403AC100022"],"award-info":[{"award-number":["202403AC100022"]}],"id":[{"id":"10.13039\/501100010982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.isci.2026.117177","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:05:10Z","timestamp":1787756710000},"page":"117177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic antitumor immune activation in melanoma using LA-PegPI polymeric gene vaccine in conjunction with PD-1 inhibition"],"prefix":"10.1016","volume":"29","author":[{"given":"WeiKe","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoXuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manzama-Esso","family":"Abi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunLei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DongYan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoHui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoRui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RuiLei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaXing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-2757","authenticated-orcid":false,"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3333-0925","authenticated-orcid":false,"given":"Hong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117177_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41571-023-00848-w","article-title":"Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma","volume":"21","author":"Klobuch","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117177_bib2","first-page":"42","article-title":"Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma","volume":"7","author":"Jalil","year":"2024","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.isci.2026.117177_bib3","article-title":"Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer","volume":"9","author":"Rubatto","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.isci.2026.117177_bib4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-025-02077-6","article-title":"Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma","volume":"57","author":"Liang","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.117177_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072367","article-title":"Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma","volume":"21","author":"Petrova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117177_bib6","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/ijms26031238","article-title":"Glycoscience in Advancing PD-1\/PD-L1-Axis-Targeted Tumor Immunotherapy","volume":"26","author":"Sun","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117177_bib7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/curroncol29020074","article-title":"A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre","volume":"29","author":"Cheema","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.isci.2026.117177_bib8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1200\/JCO.24.00400","article-title":"Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma","volume":"43","author":"Long","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117177_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s43018-022-00352-7","article-title":"Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2026.117177_bib10","article-title":"Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy","author":"Keshari","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.117177_bib11","doi-asserted-by":"crossref","first-page":"e202411009","DOI":"10.1002\/anie.202411009","article-title":"Non-Natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity","volume":"63","author":"Guerreiro","year":"2024","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.isci.2026.117177_bib12","doi-asserted-by":"crossref","first-page":"15588","DOI":"10.1021\/acs.nanolett.4c03846","article-title":"STING Nanoagonist Boosts Antitumor Immunity of Therapeutic DNA Vaccines","volume":"24","author":"Jia","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.isci.2026.117177_bib13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-024-02894-y","article-title":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1\/2 trial","volume":"30","author":"Yarchoan","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117177_bib14","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117177_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pccm.2025.02.001","article-title":"Advances in idiopathic pulmonary fibrosis diagnosis and treatment","volume":"3","author":"Liu","year":"2025","journal-title":"Chin. Med. J. Pulm. Crit. Care Med."},{"key":"10.1016\/j.isci.2026.117177_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jconrel.2022.03.016","article-title":"Development of allergic rhinitis immunotherapy using antigen-loaded small extracellular vesicles","volume":"345","author":"Liu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117177_bib17","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.7150\/thno.35059","article-title":"Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets","volume":"9","author":"Duinkerken","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.117177_bib18","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1039\/D3NA01013A","article-title":"Probing the pH-dependency of DC-SIGN\/R multivalent lectin-glycan interactions using polyvalent glycan-gold nanoparticles","volume":"6","author":"Basaran","year":"2024","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.isci.2026.117177_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tibtech.2016.10.002","article-title":"Glycan-Based Cell Targeting To Modulate Immune Responses","volume":"35","author":"Johannssen","year":"2017","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.isci.2026.117177_bib20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41467-025-56392-x","article-title":"MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma","volume":"16","author":"Niveau","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117177_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2018.08.064","article-title":"A novel galactose-PEG-conjugated biodegradable copolymer is an efficient gene delivery vector for immunotherapy of hepatocellular carcinoma","volume":"184","author":"Liu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.isci.2026.117177_bib22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/sj.gt.3302997","article-title":"Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting","volume":"14","author":"Jiang","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.isci.2026.117177_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/glycob\/cwf061","article-title":"Macrophage C-type lectin on bone marrow-derived immature dendritic cells is involved in the internalization of glycosylated antigens","volume":"12","author":"Denda-Nagai","year":"2002","journal-title":"Glycobiology"},{"key":"10.1016\/j.isci.2026.117177_bib24","doi-asserted-by":"crossref","first-page":"20686","DOI":"10.1074\/jbc.M202104200","article-title":"The macrophage C-type lectin specific for galactose\/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells","volume":"277","author":"Higashi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117177_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.117177_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nm0795-649","article-title":"Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity","volume":"1","author":"Falo","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117177_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2567.2001.01213.x","article-title":"Tumours can act as adjuvants for humoral immunity","volume":"102","author":"Brown","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.isci.2026.117177_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.117177_bib29","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1172\/JCI80008","article-title":"Tumor neoantigens: building a framework for personalized cancer immunotherapy","volume":"125","author":"Gubin","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117177_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/pharmaceutics13020142","article-title":"TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases","volume":"13","author":"Luchner","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2026.117177_bib31","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1016\/j.biomaterials.2010.07.056","article-title":"The promotion of type 1 T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion","volume":"31","author":"Chen","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.isci.2026.117177_bib32","first-page":"2231","article-title":"Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity","volume":"119","author":"Cubillos-Ruiz","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117177_bib33","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The Role of Tumor Necrosis Factor Alpha (TNF-alpha) in Autoimmune Disease and Current TNF-alpha Inhibitors in Therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117177_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.isci.2026.117177_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1615\/CritRevImmunol.2018026790","article-title":"Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells","volume":"38","author":"Bourque","year":"2018","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.117177_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","article-title":"Resistance Mechanisms to Anti-PD Cancer Immunotherapy","volume":"40","author":"Vesely","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.117177_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coi.2021.02.001","article-title":"Resistance mechanisms to checkpoint inhibitors","volume":"69","author":"Weiss","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.isci.2026.117177_bib38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s40425-019-0634-9","article-title":"Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination","volume":"7","author":"Grapin","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.117177_bib39","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117177_bib40","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41590-019-0441-y","article-title":"PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1(+)CD38(hi) cells and anti-PD-1 resistance","volume":"20","author":"Verma","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.117177_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.03.037","article-title":"Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy","volume":"207","author":"Xu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.isci.2026.117177_bib42","doi-asserted-by":"crossref","first-page":"13127","DOI":"10.1021\/acsnano.9b05974","article-title":"Nanoscale Coordination Polymer Based Nanovaccine for Tumor Immunotherapy","volume":"13","author":"Zhao","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.isci.2026.117177_bib43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/psc.2756","article-title":"Microwave-assisted solid-phase peptide synthesis of neurosecretory protein GL composed of 80 amino acid residues","volume":"21","author":"Masuda","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.isci.2026.117177_bib44","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1002\/chem.201406493","article-title":"Design and Stereoselective Synthesis of ProM-2: A Spirocyclic Diproline Mimetic with Polyproline Type II (PPII) Helix Conformation","volume":"21","author":"Reuter","year":"2015","journal-title":"Chemistry"},{"key":"10.1016\/j.isci.2026.117177_bib45","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1021\/mp400642s","article-title":"Tailored Gallium(III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging","volume":"11","author":"Sime\u010dek","year":"2014","journal-title":"Mol. Pharm."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226025551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226025551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:59:44Z","timestamp":1791593984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226025551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589004226025551"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117177","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic antitumor immune activation in melanoma using LA-PegPI polymeric gene vaccine in conjunction with PD-1 inhibition","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117177"}}